Alveda Pharmaceuticals Inc.

alvedapharma.com

Responsible for the overall day-to-day operations. Responsible for the smooth operation of the process of producing and distributing the company's goods or of providing its services.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

news image

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Read More

Pharma Tech

ADDITIONAL US$ 4 MILLION RECEIVED FOR NEXT DEVELOPMENT STEPS OF MEDINCELL'S 6-MONTH ACTIVE INJECTABLE BIORESORBABLE SUBCUTANEOUS CONTRACEPTIVE

MedinCell | December 01, 2022

news image

MedinCell has received an additional US$ 4 million payment from the Bill & Melinda Gates Foundation This amount is intended to finance the next steps of MedinCell’s program mdc-WWM in readiness to initiate the first clinical trial end of 2023 It follows US$ 11,8 million already received as part of the two successive grants for a total of up to US$ 22,5 million from the Bill & Melinda Gates Foundation to finance the development of the program up to phas...

Read More

YELLOWDOG ACCELERATES DRUG DISCOVERY FROM ONE YEAR TO LESS THAN ONE DAY WITH A 162,120 CORE SUPERCOMPUTER, ON-DEMAND

Prnewswire | September 21, 2020

news image

In drug discovery, as with many of the life sciences, data is key. The size of a dataset and the quality of the analyses has a powerful influence on the success of a given drug development programme. There is great potential for the cloud to aid drug discovery, as it offers companies the ability to dynamically scale their research and analyse more data than they would with their on-premise infrastructure. OMass Therapeutics saw an opportunity to accelerate their virtual screening capabilities by...

Read More

DTX PHARMA TO PRESENT AT THE CHARDAN VIRTUAL 4TH ANNUAL GENETIC MEDICINES EVENT

Prnewswire | September 29, 2020

news image

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., CEO of DTx Pharma, will be presenting a company overview and will participate in 1x1 meetings at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th, 2020 at 4:45 pm EDT. "At DTx, we are focused on treating the genetic drivers of disease by applying our FALCON technology plat...

Read More
news image

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Read More
news image

Pharma Tech

ADDITIONAL US$ 4 MILLION RECEIVED FOR NEXT DEVELOPMENT STEPS OF MEDINCELL'S 6-MONTH ACTIVE INJECTABLE BIORESORBABLE SUBCUTANEOUS CONTRACEPTIVE

MedinCell | December 01, 2022

MedinCell has received an additional US$ 4 million payment from the Bill & Melinda Gates Foundation This amount is intended to finance the next steps of MedinCell’s program mdc-WWM in readiness to initiate the first clinical trial end of 2023 It follows US$ 11,8 million already received as part of the two successive grants for a total of up to US$ 22,5 million from the Bill & Melinda Gates Foundation to finance the development of the program up to phas...

Read More
news image

YELLOWDOG ACCELERATES DRUG DISCOVERY FROM ONE YEAR TO LESS THAN ONE DAY WITH A 162,120 CORE SUPERCOMPUTER, ON-DEMAND

Prnewswire | September 21, 2020

In drug discovery, as with many of the life sciences, data is key. The size of a dataset and the quality of the analyses has a powerful influence on the success of a given drug development programme. There is great potential for the cloud to aid drug discovery, as it offers companies the ability to dynamically scale their research and analyse more data than they would with their on-premise infrastructure. OMass Therapeutics saw an opportunity to accelerate their virtual screening capabilities by...

Read More
news image

DTX PHARMA TO PRESENT AT THE CHARDAN VIRTUAL 4TH ANNUAL GENETIC MEDICINES EVENT

Prnewswire | September 29, 2020

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., CEO of DTx Pharma, will be presenting a company overview and will participate in 1x1 meetings at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th, 2020 at 4:45 pm EDT. "At DTx, we are focused on treating the genetic drivers of disease by applying our FALCON technology plat...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us